SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Reports New Data Showing High Response Rates in Clinical Trial of Pracinostat and Azacitidine in Myelodysplastic Syndrome